Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.biopha.2020.111138

http://scihub22266oqcxt.onion/10.1016/j.biopha.2020.111138
suck pdf from google scholar
33360781!7973050!33360781
unlimited free pdf from europmc33360781    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33360781      Biomed+Pharmacother 2021 ; 135 (ä): 111138
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • 4-Aminoquinoline compounds from the Spanish flu to COVID-19 #MMPMID33360781
  • Bazotte RB; Hirabara SM; Serdan TAD; Gritte RB; Souza-Siqueira T; Gorjao R; Masi LN; Antunes MM; Cruzat V; Pithon-Curi TC; Curi R
  • Biomed Pharmacother 2021[Mar]; 135 (ä): 111138 PMID33360781show ga
  • In 1918, quinine was used as one of the unscientifically based treatments against the H1N1 virus during the Spanish flu pandemic. Originally, quinine was extracted from the bark of Chinchona trees by South American natives of the Amazon forest, and it has been used to treat fever since the seventeenth century. The recent COVID-19 pandemic caused by Sars-Cov-2 infection has forced researchers to search for ways to prevent and treat this disease. Based on the antiviral potential of two 4-aminoquinoline compounds derived from quinine, known as chloroquine (CQ) and hydroxychloroquine (HCQ), clinical investigations for treating COVID-19 are being conducted worldwide. However, there are some discrepancies among the clinical trial outcomes.Thus, even after one hundred years of quinine use during the Spanish flu pandemic, the antiviral properties promoted by 4-aminoquinoline compounds remain unclear. The underlying molecular mechanisms by which CQ and HCQ inhibit viral replication open up the possibility of developing novel analogs of these drugs to combat COVID-19 and other viruses.
  • |*COVID-19 Drug Treatment[MESH]
  • |*Influenza Pandemic, 1918-1919/prevention & control[MESH]
  • |Aminoquinolines/pharmacology/*therapeutic use[MESH]
  • |Antimalarials/pharmacology/therapeutic use[MESH]
  • |Antiviral Agents/pharmacology/*therapeutic use[MESH]
  • |COVID-19/*epidemiology[MESH]
  • |Humans[MESH]
  • |SARS-CoV-2/*drug effects/physiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box